According to this study, reduction in the activity of the INPP5D gene in microglia (immune regulating cells in the brain) leads to increased neuroinflammation, potentially contributing to the progression of Alzheimer’s disease, paving the way for targeted treatments.

https://www.nature.com/articles/s41467-023-42819-w (open access)